Influence of Pyroptosis Induced by NOD-Like Receptor Pyrin Domain-Containing 3 Inflammasomes on Viral Myocarditis in

Huang Huang1, Jiwen Lou2, Wenhao Chen2

  • 1Science of Prescription, Academy of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.

Insights

Pyroptosis, driven by NLRP3 inflammasomes, is key in pediatric viral myocarditis (VMC). Combined gene and protein analysis of pyroptosis markers offers a more accurate diagnostic approach for VMC.

Area of Science:

  • Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Viral myocarditis (VMC) is a primary cause of heart failure in children.
  • Pyroptosis, a programmed cell death pathway involving NLRP3 inflammasomes, contributes to myocardial injury.
  • The diagnostic value of combined gene and protein expression in VMC is not well-established.

Purpose of the Study:

  • To investigate the role of NLRP3 inflammasome-mediated pyroptosis in pediatric VMC.
  • To evaluate if integrated gene and protein profiling enhances diagnostic prediction for VMC.

Main Methods:

  • 100 children were studied: 50 with VMC and 50 with dilated cardiomyopathy.
  • Myocardial tissues were analyzed for protein and gene expression of NLRP3, Caspase-1, Gasdermin D (GSDMD), and IL-1β.
  • Techniques included ELISA, immunohistochemistry, RT-PCR, and Western blotting.

Main Results:

  • Children with VMC showed significantly higher protein and gene expression of NLRP3, Caspase-1, GSDMD, and IL-1β compared to controls.
  • Expression levels of these markers positively correlated with VMC presence.
  • Combined gene and protein analysis yielded a higher diagnostic accuracy (AUC) than individual markers.

Conclusions:

  • NLRP3 inflammasome-mediated pyroptosis is integral to pediatric VMC pathogenesis.
  • Combined gene and protein assessment offers a reliable method for early VMC diagnosis and risk stratification.
  • Inflammasome-related biomarkers show potential as therapeutic targets for VMC.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
165
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
347
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
242
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
197
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
415
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378